Skip to main content
. 2008 Apr;65(Suppl 1):68–75. doi: 10.1111/j.1365-2125.2008.03138.x

Figure 1.

Figure 1

Mean machine-read QTcF changes from baseline over time following three oral doses of maraviroc (100, 300 and 900 mg); the active comparator, moxifloxacin (400 mg); or placebo. Baseline is defined as the average of the predose measurements taken on day 1 for the treatment period. *All n = 58, except for maraviroc 100 mg (n = 59). Maraviroc 100 mg (n = 59) (Inline graphic); Maraviroc 300 mg (n = 58) (▪); Maraviroc 900 mg (n = 58) (▾); Moxifloxacin 400 mg (n = 58) (▵); Placebo (n = 58/59*) (□)